• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

雄激素剥夺后前列腺癌干细胞的富集:多能性转录激活因子的上调与 LNCaP 细胞系对雄激素剥夺的抵抗一致。

Enrichment of putative prostate cancer stem cells after androgen deprivation: upregulation of pluripotency transactivators concurs with resistance to androgen deprivation in LNCaP cell lines.

机构信息

Department of Urology, David Geffen School of Medicine at UCLA, Los Angeles, California 90095-1738, USA.

出版信息

Prostate. 2013 Sep;73(13):1378-90. doi: 10.1002/pros.22685. Epub 2013 May 31.

DOI:10.1002/pros.22685
PMID:23728788
Abstract

BACKGROUND

Prostate cancer stem cells (PCSC) offer theoretical explanations to many clinical and biological behaviors of the disease in human. In contrast to approaches of using side populations and cell-surface markers to isolate and characterize the putative PCSC, we hypothesize that androgen deprivation leads to functional enrichment of putative PCSC.

METHODS AND RESULTS

Human prostate cancer lines LNCaP, LAPC4 and LAPC9 were depleted of androgen in cell cultures and in castrated SCID mice. The resultant androgen deprivation-resistant or castration-resistant populations, in particular in LNCaP and its derivative cell lines, displayed increased expression of pluripotency transactivators and significantly higher tumorigenicity. Individual tumor cell clones were isolated from castration-resistant bulk cultures of LNCaP (CR-LNCaP) and tested for tumorigenicity in male SCID mice under limiting dilution conditions. As few as 200 cells were able to form spheres in vitro, and generate tumors with similar growth kinetics as 10(6) LNCaP or 10(4) CR-LNCaP cells in vivo. These putative PCSC were CD44(+) /CD24(-) and lack the expression of prostate lineage proteins. When transplanted into the prostate of an intact male SCID mouse, these putative PCSC seemed to show limited differentiation into Ck5(+) , Ck8(+) , Ck5(+) /Ck8(+) , and AR(+) cells. On the other hand, stable transduction of LNCaP with retrovirus encoding Sox2 led to androgen-deprivation resistant growth and down-regulation of major prostate lineage gene products in vitro.

CONCLUSION

Concurrence of overexpression of pluripotency transactivators and resistance to androgen deprivation supported the role of putative PCSC in the emergence of prostate cancer resistant to androgen deprivation.

摘要

背景

前列腺癌干细胞(PCSC)为人类前列腺癌的许多临床和生物学行为提供了理论解释。与使用侧群和细胞表面标志物来分离和鉴定推测的 PCSC 的方法不同,我们假设雄激素剥夺导致推测的 PCSC 的功能富集。

方法和结果

在细胞培养和去势 SCID 小鼠中,人前列腺癌细胞系 LNCaP、LAPC4 和 LAPC9 被耗尽雄激素。由此产生的雄激素剥夺抗性或去势抗性群体,特别是在 LNCaP 及其衍生细胞系中,显示出多能转录因子的表达增加,并具有明显更高的致瘤性。从去势抗性 LNCaP (CR-LNCaP)的 bulk 培养物中分离单个肿瘤细胞克隆,并在雄性 SCID 小鼠中进行致瘤性测试,采用有限稀释条件。在体外,少至 200 个细胞能够形成球体,并在体内产生与 10(6)个 LNCaP 或 10(4)个 CR-LNCaP 细胞相似生长动力学的肿瘤。这些推测的 PCSC 是 CD44(+)/CD24(-),缺乏前列腺谱系蛋白的表达。当将这些推测的 PCSC 移植到完整雄性 SCID 小鼠的前列腺中时,它们似乎显示出向 Ck5(+)、Ck8(+)、Ck5(+)/Ck8(+)和 AR(+)细胞的有限分化。另一方面,逆转录病毒编码 Sox2 稳定转导 LNCaP 导致体外雄激素剥夺抗性生长和主要前列腺谱系基因产物的下调。

结论

多能转录因子的过度表达和对雄激素剥夺的抗性的并存支持了推测的 PCSC 在雄激素剥夺抵抗的前列腺癌发生中的作用。

相似文献

1
Enrichment of putative prostate cancer stem cells after androgen deprivation: upregulation of pluripotency transactivators concurs with resistance to androgen deprivation in LNCaP cell lines.雄激素剥夺后前列腺癌干细胞的富集:多能性转录激活因子的上调与 LNCaP 细胞系对雄激素剥夺的抵抗一致。
Prostate. 2013 Sep;73(13):1378-90. doi: 10.1002/pros.22685. Epub 2013 May 31.
2
Establishment and characterization of androgen-independent human prostate cancer cell lines, LN-REC4 and LNCaP-SF, from LNCaP.从LNCaP细胞系建立雄激素非依赖性人前列腺癌细胞系LN-REC4和LNCaP-SF并对其进行特性分析。
Int J Urol. 2007 Mar;14(3):233-9. doi: 10.1111/j.1442-2042.2007.01532.x.
3
Androgen deprivation induces selective outgrowth of aggressive hormone-refractory prostate cancer clones expressing distinct cellular and molecular properties not present in parental androgen-dependent cancer cells.雄激素剥夺诱导侵袭性激素难治性前列腺癌克隆的选择性生长,这些克隆表达亲代雄激素依赖性癌细胞中不存在的独特细胞和分子特性。
Cancer J. 2000 Jul-Aug;6(4):220-33.
4
Down-regulation of calcium/calmodulin-dependent protein kinase kinase 2 by androgen deprivation induces castration-resistant prostate cancer.雄激素剥夺下调钙/钙调蛋白依赖性蛋白激酶激酶 2 诱导去势抵抗性前列腺癌。
Prostate. 2012 Dec 1;72(16):1789-801. doi: 10.1002/pros.22533. Epub 2012 May 1.
5
N-cadherin increases after androgen deprivation and is associated with metastasis in prostate cancer.N-钙黏蛋白在雄激素剥夺后增加,与前列腺癌转移相关。
Endocr Relat Cancer. 2010 May 18;17(2):469-79. doi: 10.1677/ERC-10-0015. Print 2010 Jun.
6
Development of an androgen-deprivation induced and androgen suppressed human prostate cancer cell line.一种雄激素剥夺诱导和雄激素抑制的人前列腺癌细胞系的建立。
Prostate. 2007 Sep 1;67(12):1293-300. doi: 10.1002/pros.20621.
7
The hippo pathway effector YAP regulates motility, invasion, and castration-resistant growth of prostate cancer cells.河马通路效应因子YAP调节前列腺癌细胞的运动性、侵袭性和去势抵抗性生长。
Mol Cell Biol. 2015 Apr;35(8):1350-62. doi: 10.1128/MCB.00102-15. Epub 2015 Feb 2.
8
NE-10 neuroendocrine cancer promotes the LNCaP xenograft growth in castrated mice.NE-10神经内分泌癌促进去势小鼠体内LNCaP异种移植瘤的生长。
Cancer Res. 2004 Aug 1;64(15):5489-95. doi: 10.1158/0008-5472.CAN-03-3117.
9
Androgen deprivation causes epithelial-mesenchymal transition in the prostate: implications for androgen-deprivation therapy.雄激素剥夺导致前列腺中的上皮-间充质转化:对雄激素剥夺治疗的影响。
Cancer Res. 2012 Jan 15;72(2):527-36. doi: 10.1158/0008-5472.CAN-11-3004. Epub 2011 Nov 22.
10
Androgen receptor-dependent regulation of Bcl-xL expression: Implication in prostate cancer progression.雄激素受体依赖性Bcl-xL表达调控:对前列腺癌进展的影响。
Prostate. 2008 Mar 1;68(4):453-61. doi: 10.1002/pros.20723.

引用本文的文献

1
The role of SOX transcription factors in prostate cancer: Focusing on SOX2.SOX转录因子在前列腺癌中的作用:聚焦于SOX2
Genes Dis. 2025 May 21;12(6):101692. doi: 10.1016/j.gendis.2025.101692. eCollection 2025 Nov.
2
IMPA1-derived inositol maintains stemness in castration-resistant prostate cancer via IMPDH2 activation.IMP A1 衍生的肌醇通过 IMPDH2 的激活来维持去势抵抗性前列腺癌的干性。
J Exp Med. 2024 Nov 4;221(11). doi: 10.1084/jem.20231832. Epub 2024 Oct 29.
3
Cancer Stem Cells and Androgen Receptor Signaling: Partners in Disease Progression.
癌症干细胞与雄激素受体信号:疾病进展中的伙伴。
Int J Mol Sci. 2023 Oct 11;24(20):15085. doi: 10.3390/ijms242015085.
4
The driver role of JAK-STAT signalling in cancer stemness capabilities leading to new therapeutic strategies for therapy- and castration-resistant prostate cancer.JAK-STAT 信号通路在癌症干细胞特性中的驱动作用,为治疗和去势抵抗性前列腺癌的新治疗策略提供了依据。
Clin Transl Med. 2022 Aug;12(8):e978. doi: 10.1002/ctm2.978.
5
BAZ2A-mediated repression via H3K14ac-marked enhancers promotes prostate cancer stem cells.BAZ2A 通过 H3K14ac 标记的增强子介导的抑制作用促进前列腺癌干细胞。
EMBO Rep. 2021 Nov 4;22(11):e53014. doi: 10.15252/embr.202153014. Epub 2021 Aug 17.
6
Crosstalk Between AR and Wnt Signaling Promotes Castration-Resistant Prostate Cancer Growth.雄激素受体(AR)与Wnt信号通路之间的相互作用促进去势抵抗性前列腺癌的生长。
Onco Targets Ther. 2020 Sep 18;13:9257-9267. doi: 10.2147/OTT.S245861. eCollection 2020.
7
Cellular and Molecular Mechanisms Underlying Prostate Cancer Development: Therapeutic Implications.前列腺癌发生的细胞和分子机制:治疗意义
Medicines (Basel). 2019 Jul 30;6(3):82. doi: 10.3390/medicines6030082.
8
Identification of an IL-1-induced gene expression pattern in AR PCa cells that mimics the molecular phenotype of AR PCa cells.在雄激素受体(AR)阳性前列腺癌细胞中鉴定出一种白细胞介素-1诱导的基因表达模式,该模式模拟了AR阳性前列腺癌细胞的分子表型。
Prostate. 2018 Jun;78(8):595-606. doi: 10.1002/pros.23504. Epub 2018 Mar 11.
9
Cellular plasticity and the neuroendocrine phenotype in prostate cancer.前列腺癌中的细胞可塑性和神经内分泌表型。
Nat Rev Urol. 2018 May;15(5):271-286. doi: 10.1038/nrurol.2018.22. Epub 2018 Feb 20.
10
Exploiting AR-Regulated Drug Transport to Induce Sensitivity to the Survivin Inhibitor YM155.利用AR调节的药物转运来诱导对生存素抑制剂YM155的敏感性。
Mol Cancer Res. 2017 May;15(5):521-531. doi: 10.1158/1541-7786.MCR-16-0315-T.